Гематология / лейкозы / лимфомы

Leukemia drug data suggested a different way to treat diabetes. A new biotech will test that idea

Leukemia drug data suggested a different way to treat diabetes. A new biotech will test that idea STAT

Immune protein loss may drive rare stomach lymphoma in H. pylori infections

Roughly half the world's population is infected with the stomach bacterium Helicobacter pylori, which is responsible for about 90% of gastric cancers. However, until now, it has been unclear why some H. pylori infections lead to a rare form of lymphoma in the stomach while others don't.

Case Discussion: Treatment Sequencing After Prior BCMA-Directed Therapy in Relapsed/Refractory Multiple Myeloma

Managing Treatment-Related Toxicities in Relapsed/Refractory Multiple Myeloma

Case Discussion: Choosing Between CAR-T Cell Therapy and BCMA Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma

Treatment-Related Toxicities in Relapsed/Refractory Multiple Myeloma

Lymphoma Treatment Is Changing Fast: What Patients Should Know

Lymphoma Treatment Is Changing Fast: What Patients Should Know Cure Today

Dual-drug approach burns out leukemia cells by pressing accelerator and brake simultaneously

Pushing the accelerator and the brake at the same time is rarely a good idea. But researchers at the University of Gothenburg are using this approach to treat leukemia. A new drug forces cancer cells to keep working hard even though they have run out of energy. The first study in mice shows very promising results.

PeproMene Bio Announces Publication in The Lancet of Breakthrough Phase 1 Clinical Trial Results Demonstrating Deep and Durable Complete Responses in Relapsed/Refractory B-cell Lymphomas, including after prior CD19 CAR T-cell failure

PeproMene Bio Announces Publication in The Lancet of Breakthrough Phase 1 Clinical Trial Results Demonstrating Deep and Durable Complete Responses in Relapsed/Refractory B-cell Lymphomas, including after prior CD19 CAR T-cell failure PA Media

Ученые нашли новый способ лечения острого миелоидного лейкоза

Ученые нашли новый способ лечения острого миелоидного лейкоза Наука Mail

Patient questionnaires may add a new layer to chronic lymphocytic leukemia prognosis

Patients' responses to questions routinely raised by oncologists may provide important clues about their chances of survival from chronic lymphocytic leukemia (CLL), according to a new study published in the journal Therapeutic Advances in Hematology.

Рефрактерная множественная миелома: этентамиг снизил риск смерти на 60%

Рефрактерная множественная миелома: этентамиг снизил риск смерти на 60% Medvestnik

Tumor biology could guide mantle cell lymphoma treatment from the time of diagnosis

Today, treatment decisions for patients with mantle cell lymphoma are heavily based on age alone, although the disease can range from slow-growing (indolent) to very aggressive. In a new journal article, Ingrid Glimelius and co-authors suggest that it is time to let the disease's biology also guide treatment—and…

Less-intensive drug combination is more effective in treating acute myeloid leukemia, clinical trial finds

Investigators from the Mass General Brigham Cancer Institute have found that adults with newly diagnosed acute myeloid leukemia (AML) receiving a less-intensive combination of azacitidine and venetoclax had more than twice as much time before treatment failed, the leukemia returned or worsened, or they died, compared…

Case Discussion: Selecting BCMA Bispecific Therapy for a Patient With Relapsed/Refractory Multiple Myeloma and Limited Access to CAR-T